FRANK FENTON: Open Payments
NPI 1215081211 · WALLED LAKE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,813 in 145 payments from 24 companies in 2025. Trend: 2023 $1,691 · 2024 $2,321 · 2025 $3,813
Food & beverage: $3,813
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $625 |
| AstraZeneca Pharmaceuticals LP | 22 | $583 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $484 |
| Otsuka America Pharmaceutical, Inc. | 17 | $376 |
| PFIZER INC. | 16 | $311 |
| Vanda Pharmaceuticals Inc. | 10 | $187 |
| Amgen Inc. | 4 | $175 |
| Indivior Inc. | 2 | $153 |
| Alnylam Pharmaceuticals Inc. | 1 | $147 |
| Lilly USA, LLC | 9 | $124 |
Products named: CAPLYTA, REXULTI, FARXIGA, Ozempic, AIRSUPRA, Wegovy, FANAPT, SUBLOCADE.
Industry payments across MI — which companies pay providers there.
